###begin article-title 0
###xml 18 23 <span type="species:ncbi:9606">Human</span>
###xml 98 103 <span type="species:ncbi:9606">Human</span>
Identification of Human GnIH Homologs, RFRP-1 and RFRP-3, and the Cognate Receptor, GPR147 in the Human Hypothalamic Pituitary Axis
###end article-title 0
###begin p 1
Conceived and designed the experiments: TU KT RPM GB. Performed the experiments: TU KM AP TO VSC HM. Analyzed the data: TU KM AP TO VSC HM. Contributed reagents/materials/analysis tools: TU KM AP TO VSC HM. Wrote the paper: TU KT RPM GB.
###end p 1
###begin p 2
###xml 156 157 156 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 528 529 528 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 560 561 560 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 973 980 973 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 1237 1239 1237 1239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 322 327 <span type="species:ncbi:9606">human</span>
###xml 439 444 <span type="species:ncbi:9606">human</span>
###xml 531 536 <span type="species:ncbi:9606">human</span>
###xml 563 568 <span type="species:ncbi:9606">human</span>
###xml 879 884 <span type="species:ncbi:9606">human</span>
###xml 1099 1104 <span type="species:ncbi:9606">Human</span>
###xml 1199 1204 <span type="species:ncbi:9940">sheep</span>
###xml 1368 1373 <span type="species:ncbi:9606">human</span>
###xml 1401 1406 <span type="species:ncbi:9606">human</span>
###xml 1474 1479 <span type="species:ncbi:9940">sheep</span>
###xml 1572 1575 <span type="species:ncbi:9606">man</span>
The existence of a hypothalamic gonadotropin-inhibiting system has been elusive. A neuropeptide named gonadotropin-inhibitory hormone (GnIH, SIKPSAYLPLRF-NH2) which directly inhibits gonadotropin synthesis and release from the pituitary was recently identified in quail hypothalamus. Here we identify GnIH homologs in the human hypothalamus and characterize their distribution and biological activity. GnIH homologs were isolated from the human hypothalamus by immunoaffinity purification, and then identified as MPHSFANLPLRF-NH2 (human RFRP-1) and VPNLPQRF-NH2 (human RFRP-3) by mass spectrometry. Immunocytochemistry revealed GnIH-immunoreactive neuronal cell bodies in the dorsomedial region of the hypothalamus with axonal projections to GnRH neurons in the preoptic area as well as to the median eminence. RT-PCR and subsequent DNA sequencing of the PCR products identified human GnIH receptor (GPR147) mRNA expression in the hypothalamus as well as in the pituitary. In situ hybridization further identified the expression of GPR147 mRNA in luteinizing hormone producing cells (gonadotropes). Human RFRP-3 has recently been shown to be a potent inhibitor of gonadotropin secretion in cultured sheep pituitary cells by inhibiting Ca2+ mobilization. It also directly modulates GnRH neuron firing. The identification of two forms of GnIH (RFRP-1 and RFRP-3) in the human hypothalamus which targets human GnRH neurons and gonadotropes and potently inhibit gonadotropin in sheep models provides a new paradigm for the regulation of hypothalamic-pituitary-gonadal axis in man and a novel means for manipulating reproductive functions.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 90 93 90 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Matsuo1">[1]</xref>
###xml 94 97 94 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Miyamoto1">[5]</xref>
###xml 175 178 175 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-McCann1">[6]</xref>
###xml 179 182 179 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Balen1">[8]</xref>
###xml 348 351 348 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Tsutsui1">[9]</xref>
###xml 484 487 484 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Tsutsui1">[9]</xref>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Osugi1">[13]</xref>
###xml 675 678 675 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Tsutsui1">[9]</xref>
###xml 679 683 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Osugi1">[13]</xref>
###xml 783 787 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Yin1">[14]</xref>
###xml 882 886 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ciccone1">[15]</xref>
###xml 991 995 991 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ubuka2">[16]</xref>
###xml 1062 1065 1062 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Tsutsui1">[9]</xref>
###xml 1066 1070 1066 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ubuka3">[19]</xref>
Gonadotropin-releasing hormone (GnRH) is the primary stimulator of gonadotropin secretion [1]-[5]. A neuropeptide inhibitor of gonadotropin secretion has also been postulated [6]-[8]. The recent identification of an avian hypothalamic dodecapeptide that inhibits pituitary gonadotropin release implies that such a factor might exist in vertebrates [9]. This factor, named gonadotropin-inhibitory hormone (GnIH), is synthesized in neurons of the paraventricular nucleus (PVN) in birds [9]-[13]. The GnIH neurons project to the median eminence, providing neuroanatomical infrastructure to allow secretion into the hypophysial portal system and thus regulate pituitary function [9]-[13]. The cognate G protein-coupled receptor (GPCR) for GnIH was also identified in the quail pituitary [14] and GnIH was shown to act on the pituitary to suppress synthesis and release of gonadotropins [15]. Accordingly, GnIH inhibits the development and maintenance of gonadotropin-dependent gonadal functions [16]. Thus, while GnIH serves an important physiological role in birds [9]-[19], there has been limited evidence that the same is true for mammals.
###end p 4
###begin p 5
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ukena2">[20]</xref>
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Tsutsui2">[21]</xref>
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Fukusumi1">[22]</xref>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ukena2">[20]</xref>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Tsutsui2">[21]</xref>
###xml 347 351 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Yin1">[14]</xref>
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ukena2">[20]</xref>
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Fukusumi1">[22]</xref>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Kriegsfeld1">[23]</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Johnson1">[24]</xref>
###xml 496 500 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Murakami1">[25]</xref>
###xml 500 507 500 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 583 590 583 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 641 645 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Clarke1">[26]</xref>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Sari1">[27]</xref>
###xml 663 667 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Kadokawa1">[28]</xref>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 379 382 <span type="species:ncbi:10116">rat</span>
###xml 460 475 <span type="species:ncbi:10036">Syrian hamsters</span>
###xml 485 489 <span type="species:ncbi:10116">rats</span>
###xml 635 640 <span type="species:ncbi:9940">sheep</span>
###xml 656 662 <span type="species:ncbi:9913">cattle</span>
GnIH homologs are present in the brains of non-human vertebrates, including mammals, amphibians and fish [20], [21]. These peptides belong to the RFamide-related peptide (RFRP) [22] family and possess a characteristic C-terminal LPXRFamide (X = L or Q) motif [20], [21]. The receptors for GnIH homologs have also been characterized in vertebrates [14], [20]-[22]. Quail GnIH and rat GnIH peptide homolog, RFRP-3, inhibits luteinizing hormone (LH) secretion in Syrian hamsters [23] and rats [24], [25]in vivo. It was recently shown that RFRP-3 inhibits pulsatile gonadotropin release in vivo as well as from cultured pituitary cells in sheep [26], [27] and cattle [28], suggesting that a hypothalamic gonadotropin-inhibitory system also exists in mammals. Accordingly, a GnIH/RFRP system might be a conserved property of vertebrates. However, these mammalian GnIH peptide homologs were inferred from genomic sequences and the processed peptides have yet to be unequivocally identified.
###end p 5
###begin p 6
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Hinuma1">[29]</xref>
###xml 735 742 735 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 985 992 985 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1048 1050 1048 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1064 1068 1064 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Clarke1">[26]</xref>
###xml 78 83 <span type="species:ncbi:9606">human</span>
###xml 258 263 <span type="species:ncbi:9606">human</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 879 884 <span type="species:ncbi:9606">human</span>
###xml 979 984 <span type="species:ncbi:9940">sheep</span>
###xml 1272 1277 <span type="species:ncbi:9606">human</span>
Here we first analyzed the existence of GnIH-immunoreactive (-ir) material in human hypothalamus by immunocytochemistry (ICC). We further investigated whether there were interactions of GnIH-ir neurons with GnRH neurons by double-label ICC. We then isolated human GnIH peptide homologs (human RFRP-1 and RFRP-3) by immunoaffinity purification and identified the structure of the peptides by mass spectrometry. A G-protein coupled receptor, GPR147 (OT7T022) has been identified as the cognate receptor for RFRPs in studies investigating the role of these peptides in the central nervous system [29]. Accordingly GPR147 mRNA expression was analyzed in the hypothalamus and the pituitary by RT-PCR and DNA sequencing of the PCR products. In situ hybridization further revealed the expression of GPR147 mRNA in pituitary cells including luteinizing hormone (LH) producing cells. The human RFRP-3 was recently shown to potently inhibit GnRH stimulation of gonadotropin secretion from sheep in vivo and from cultured gonadotropes through inhibition of Ca2+ mobilization [26]. The identification of RFRP-1 and RFRP-3 and the cognate receptor GPR147 along with the demonstration of gonadotropin inhibition prompts revision of our understanding of the central control mechanism of human reproduction.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 39 44 <span type="species:ncbi:9606">human</span>
Localization of GnIH-ir neurons in the human hypothalamus
###end title 8
###begin p 9
###xml 121 132 121 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008400-g001">Fig. 1A, 1B</xref>
###xml 207 214 207 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008400-g001">Fig. 1A</xref>
###xml 277 284 277 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008400-g001">Fig. 1C</xref>
###xml 394 401 394 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008400-g001">Fig. 1D</xref>
###xml 101 106 <span type="species:ncbi:9606">human</span>
ICC using avian GnIH antibody identified a group of GnIH-ir neurons in the dorsomedial region of the human hypothalamus (Fig. 1A, 1B). Some GnIH-ir fibers emanated from the infundibulum of the hypothalamus (Fig. 1A) and terminated in the external layer of the median eminence (Fig. 1C). GnIH-ir neuronal axon terminal-like structures were further observed on GnRH neurons in the preoptic area (Fig. 1D).
###end p 9
###begin title 10
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 84 89 <span type="species:ncbi:9606">human</span>
GnIH immunoreactive neurons in the human hypothalamus and GnIH receptor mRNA in the human pituitary.
###end title 10
###begin p 11
###xml 235 236 235 236 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 309 310 305 306 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 439 440 431 432 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 636 643 624 631 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E and F</bold>
###xml 645 652 633 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 737 738 725 726 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 810 811 798 799 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 829 830 817 818 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 853 854 841 842 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 948 955 932 939 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G and H</bold>
###xml 957 964 941 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 1002 1003 986 987 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1059 1060 1043 1044 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 670 675 <span type="species:ncbi:9606">human</span>
###xml 711 716 <span type="species:ncbi:9606">human</span>
(A) Coronal section of adult human hypothalamus showing GnIH immunoreactive (-ir) neurons clustered in the dorsomedial region of the hypothalamus with their fibers extending to the infundibulum (INF). III, third ventricle. Bar, 1 mm. (B) Higher magnification of GnIH-ir neuronal cell bodies. Bar, 50 microm. (C) Sagittal section of the median eminence showing dense population of GnIH-ir fibers within the external layer. Bar, 10 microm. (D) GnIH-ir axon terminal like structures (stained in purple, indicated by black arrows) in close proximity to a GnRH-ir neuronal cell body (stained in brown) in the preoptic area. Bar, 50 microm. (E and F) In situ hybridization of human GnIH receptor (GPR147) mRNA in the human anterior pituitary (E) in combination with immunocytochemistry for luteinizing hormone (LH) (F). Red arrows in (E) and white arrows in (F) in equivalent positions show cells which express both GPR147 mRNA and LH. Bars, 30 microm. (G and H) In situ hybridization using sense RNA probe (G) and immunocytochemistry without LH primary antiserum (H) served as controls. Bars, 30 microm.
###end p 11
###begin title 12
###xml 25 30 <span type="species:ncbi:9606">human</span>
Identification of mature human GnIH peptide homologs
###end title 12
###begin p 13
###xml 484 491 484 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008400-g002">Fig. 2A</xref>
###xml 725 732 725 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008400-g002">Fig. 2A</xref>
###xml 992 993 992 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 996 1003 996 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008400-g002">Fig. 2B</xref>
###xml 1103 1104 1103 1104 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1125 1126 1125 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1261 1262 1261 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1265 1272 1265 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008400-g002">Fig. 2C</xref>
###xml 1368 1369 1368 1369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1389 1390 1389 1390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1812 1813 1812 1813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1841 1842 1841 1842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1846 1853 1846 1853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008400-t001">Table 1</xref>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 186 191 <span type="species:ncbi:9606">human</span>
###xml 294 300 <span type="species:ncbi:9606">humans</span>
###xml 564 569 <span type="species:ncbi:9606">human</span>
###xml 587 592 <span type="species:ncbi:9606">human</span>
###xml 672 677 <span type="species:ncbi:9606">human</span>
###xml 766 769 <span type="species:ncbi:9606">men</span>
###xml 774 779 <span type="species:ncbi:9606">women</span>
###xml 812 817 <span type="species:ncbi:9606">human</span>
###xml 924 929 <span type="species:ncbi:9606">human</span>
###xml 1074 1079 <span type="species:ncbi:9606">human</span>
###xml 1343 1348 <span type="species:ncbi:9606">human</span>
###xml 1961 1966 <span type="species:ncbi:9606">human</span>
We identified the fully processed forms of GnIH homologs in the extract of human hypothalamus by using an avian GnIH antibody-conjugated immunoaffinity column and mass spectrometry. The human genome database revealed that a putative homolog of the GnIH precursor polypeptide gene is present in humans (GenBank NM_022150; 29), but the processed peptide products had not been identified until now. Because of several potential cleavage sites in the putative GnIH precursor polypeptide (Fig. 2A), there were various possible GnIH peptide products. Thus, based on the human genome, putative human RFRP-1 could be 12, 20, 24, 29, 37, 40, 44, 49 or 54 amino acids in length and human RFRP-3 could be 8 or 31 amino acids in length (Fig. 2A). Hypothalamic tissue from adult men and women was used to purify and identify human RFRP peptides by immunoaffinity purification followed by MALDI-TOF MS. GnIH-ir material in the extract of human hypothalamus showed a molecular ion peak of 1428.85 m/z ([M+H]+) (Fig. 2B). This value was in accord with the theoretical mass of the predicted human RFRP-1 (MPHSFANLPLRF-NH2) [1428.75 m/z ([M+H]+)]. GnIH antiserum isolated another immunoreactive material in the hypothalamic extracts with a molecular ion peak of 969.48 m/z ([M+H]+) (Fig. 2C). This value was in accord with the theoretical mass of the predicted human RFRP-3 (VPNLPQRF-NH2) [969.56 m/z ([M+H]+)]. To confirm the data obtained by MALDI-TOF MS analyses of the endogenous GnIH-ir material, peptides having the suggested sequences were synthesized and compared with the native peptides for retention time on reverse-phase high performance liquid chromatography (HPLC) and mass number. Both native and synthetic peptides showed a similar retention time using HPLC and a similar molecular mass [RFRP-1: 1428.91 m/z ([M+H]+), RFRP-3: 969.81 m/z ([M+H]+)] (Table 1). Furthermore, fragmentation of the synthetic and native peptides by tandem MS confirmed the structures of human RFRP-1 and RFRP-3.
###end p 13
###begin title 14
###xml 18 23 <span type="species:ncbi:9606">human</span>
Identification of human GnIH homologs.
###end title 14
###begin p 15
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Hinuma1">[29]</xref>
###xml 579 580 579 580 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 640 641 640 641 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 625 630 <span type="species:ncbi:9606">human</span>
###xml 686 691 <span type="species:ncbi:9606">human</span>
(A) Amino acid sequence of the human GnIH precursor polypeptide. The arrowhead shows the predicted cleavage site of the N-terminal secretory signal peptide [29]. Two peptide sequences which have LPXRF (X = L or Q) sequence at their C-termini with glycine as an amidation signal and arginine as an endoproteolytic basic amino acid are underlined (RFRP-1, RFRP-3). One peptide sequence which has LPLRS sequence at its C-terminus with glycine and arginine is underlined with a broken line (RFRP-2). The basic amino acids which could be proteolytic cleavage sites are shown in red. (B) Chromatogram of MALDI-TOF MS of the native human RFRP-1. (C) Chromatogram of MALDI-TOF MS of the native human RFRP-3.
###end p 15
###begin title 16
###xml 33 38 <span type="species:ncbi:9606">Human</span>
Behavior of Native and Synthetic Human RFRP-1 and RFRP-3 on MALDI-TOF MS.
###end title 16
###begin title 17
###xml 33 38 <span type="species:ncbi:9606">human</span>
Expression of GPR147 mRNA in the human hypothalamus and in the pituitary
###end title 17
###begin p 18
###xml 279 285 279 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008400-g003">Fig. 3</xref>
###xml 671 683 671 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 768 775 768 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 967 982 967 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008400-g001">Fig. 1, E and F</xref>
###xml 985 992 985 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 1030 1037 1030 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008400-g001">Fig. 1G</xref>
###xml 1093 1100 1093 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008400-g001">Fig. 1H</xref>
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 671 683 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 863 868 <span type="species:ncbi:9606">human</span>
###xml 941 946 <span type="species:ncbi:9606">human</span>
The expression of human RFRP receptor, GPR147, mRNA was analyzed in the human hypothalamus as well as in the pituitary. Combinations of various forward primers (F1, F2 and F3) and a reverse primer (R) produced expected RT-PCR products of 479, 415 and 325 bp in the hypothalamus (Fig. 3). The PCR products were sequenced and confirmed to be derived from GPR147 mRNA (GenBank NM_022146). RT-PCR and subsequent DNA sequencing of the PCR products also identified the same 479, 415 and 325 bp GPR147 cDNAs expressed in the pituitary. F1/R and F3/R primer combinations produced additional RT-PCR products in the pituitary; DNA sequencing identified that they were derived from Homo sapiens RAB11 family interacting protein 1 and NEDD4 binding protein 1 mRNAs, respectively. In situ hybridization using an antisense RNA probe for GPR147 mRNA in conjunction with ICC for human LH showed the expression of GPR147 mRNA in the gonadotrope of the adult human anterior pituitary (Fig. 1, E and F). In situ hybridization using sense RNA probe (Fig. 1G) and immunocytochemistry without LH primary antiserum (Fig. 1H) served as controls.
###end p 18
###begin title 19
###xml 32 37 <span type="species:ncbi:9606">human</span>
Gel image of RT-PCR products of human GnIH receptor (GPR147) mRNA.
###end title 19
###begin p 20
###xml 552 564 548 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 552 564 <span type="species:ncbi:9606">Homo sapiens</span>
cDNAs corresponding to 1 microg total RNA extracted from human hypothalamus or pituitary were used for a PCR reaction. Combinations of forward primers (F1, F2 and F3) with a reverse primer (R) produced RT-PCR products of 479, 415 and 325 bp using hypothalamic and pituitary cDNAs as the template. The PCR products were sequenced and confirmed to be derived from GPR147 mRNA (NM_022146). F1/R and F3/R primer combinations produced additional RT-PCR products in the pituitary although the subsequent DNA sequencing identified that they were derived from Homo sapiens RAB11 family interacting protein 1 and NEDD4 binding protein 1 mRNAs, respectively.
###end p 20
###begin title 21
Discussion
###end title 21
###begin p 22
###xml 260 261 260 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 292 293 292 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 263 268 <span type="species:ncbi:9606">human</span>
###xml 295 300 <span type="species:ncbi:9606">human</span>
###xml 314 319 <span type="species:ncbi:9606">human</span>
We identified the fully processed forms of GnIH homologs in an extract of human hypothalamus by using an avian GnIH antibody-conjugated immunoaffinity column and mass spectrometry. Two GnIH homologs were identified, the structures of which were MPHSFANLPLRF-NH2 (human RFRP-1) and VPNLPQRF-NH2 (human RFRP-3). The human genome database also predicted the presence of an RFRP-like peptide which has a C-terminus LPLRSamide motif, but this was not detected, possibly because of the difference in the C-terminal amino acid compared to avian GnIH, or because this peptide is not processed from the precursor. The precise mechanism of how the GnIH/RFRP precursor protein is processed into mature peptides and how this process differs between species is unknown.
###end p 22
###begin p 23
###xml 519 523 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Bentley1">[17]</xref>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ubuka3">[19]</xref>
###xml 539 543 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Kriegsfeld1">[23]</xref>
###xml 550 554 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Smith1">[31]</xref>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ubuka5">[32]</xref>
###xml 643 647 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ubuka3">[19]</xref>
###xml 865 869 865 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Wu1">[33]</xref>
###xml 871 875 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ducret1">[34]</xref>
###xml 928 932 928 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Anderson1">[35]</xref>
###xml 1172 1179 1172 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 1593 1597 1593 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Clarke1">[26]</xref>
###xml 1599 1603 1599 1603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Sari1">[27]</xref>
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 198 203 <span type="species:ncbi:9940">sheep</span>
###xml 544 549 <span type="species:ncbi:9940">sheep</span>
###xml 575 584 <span type="species:ncbi:9172">starlings</span>
###xml 696 701 <span type="species:ncbi:9606">human</span>
###xml 1105 1110 <span type="species:ncbi:9606">human</span>
###xml 1254 1259 <span type="species:ncbi:9606">human</span>
###xml 1337 1342 <span type="species:ncbi:9606">human</span>
###xml 1376 1381 <span type="species:ncbi:9606">human</span>
###xml 1587 1592 <span type="species:ncbi:9940">sheep</span>
GnIH-ir neurons were observed in the dorsomedial region of the human hypothalamus. The location of GnIH neuronal cell bodies were in general agreement to hamsters (dorsomedial hypothalamus; 23) and sheep (dorsomedial hypothalamic nucleus and paraventricular nucleus; 26). GnIH-ir axon terminal like structures were observed in close proximity to GnRH neurons in the preoptic area suggesting the regulation of GnRH neurons by GnIH. The interaction of GnIH-ir fibers with GnRH neurons is consistent with results in birds [17], [19], rodents [23] sheep [31] and monkey [32]. In starlings, GnIH receptor (GPR147) mRNA is expressed in GnRH neurons [19] and we demonstrated expression of the GPR147 in human hypothalamus. The possibility that GnIH affects GnRH neuron activity is supported by the recent demonstration that RFRP administration reduces the firing activity [33], [34] and immediate early gene expression in GnRH neurons [35]. GnIH-ir axons also projected to the neurosecretory zone of the median eminence suggesting that GnIH might also directly regulate pituitary function. The expression of the human GPR147 mRNA in the pituitary supports this notion. Moreover, in situ hybridization for GPR147 mRNA in conjunction with immunocytochemistry for human LH further showed the expression of GPR147 mRNA in gonadotropes of the adult human anterior pituitary. Accordingly, human GnIH homologs may regulate gonadotropin secretion by inhibiting GnRH neurons as well as directly acting on gonadotrope cells in the pituitary as was clearly demonstrated in isolated pituitary cells in the sheep [26], [27].
###end p 23
###begin p 24
###xml 1011 1018 1008 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1111 1115 1108 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Clarke1">[26]</xref>
###xml 1117 1121 1114 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Sari1">[27]</xref>
###xml 1332 1336 1329 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Wu1">[33]</xref>
###xml 1337 1341 1334 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Anderson1">[35]</xref>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 134 139 <span type="species:ncbi:9606">human</span>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 261 266 <span type="species:ncbi:9606">human</span>
###xml 319 324 <span type="species:ncbi:9606">human</span>
###xml 427 432 <span type="species:ncbi:9606">human</span>
###xml 445 450 <span type="species:ncbi:10090">mouse</span>
###xml 692 697 <span type="species:ncbi:9606">human</span>
###xml 908 913 <span type="species:ncbi:9606">human</span>
###xml 956 961 <span type="species:ncbi:9940">sheep</span>
###xml 1022 1027 <span type="species:ncbi:9940">sheep</span>
###xml 1089 1094 <span type="species:ncbi:9940">sheep</span>
###xml 1244 1247 <span type="species:ncbi:9606">man</span>
###xml 1408 1411 <span type="species:ncbi:9606">man</span>
Our identification of RFRP-1 and RFRP-3 peptides in the human hypothalamus and the ICC demonstration of targeting GnRH neurons in the human hypothalamus along with the expression of GPR147 in human gonadotropes provide a cogent framework for RFRP regulation of human reproduction. The question arises as to whether the human RPRP peptides are biologically active and inhibit gonadotropins. Similarly, we studied the effects of human RFRP on the mouse gonadotrope LbetaT2 cell line but detected no effects on any signaling pathway. When we checked GPR147 expression by RT-PCR no products were detected in this immature gonadotrope cell line (data not shown). We detected inhibitory effects in human fetal pituitary cells, but these were inconsistent even though they exhibited robust gonadotropin responses to GnRH (data not shown). This variability may be due to the immaturity of the gonadotropes. However, human RFRP-3, which is identical in sequence to sheep RFRP-3, potently inhibits gonadotropin secretion in vivo in sheep and GnRH stimulation of gonadotropin secretion from cultured sheep pituitary cells [26], [27]. This strongly suggests RFRP-3 would also be active in the direct inhibition of gonadotropin release from gonadotropes in man. The demonstration that RFRP regulates GnRH neuron firing and early gene expression [33]-[35] suggests that the peptides may also be effective at this level in man. The question also arises as to whether RFRP-1 and RFRP-3 have similar or different functions. It appears from the large pain literature that they both bind GPR147 with similar affinity and recruit similar signalling pathways. Thus, the presence of two peptide products from the same gene may be a means for signal amplification.
###end p 24
###begin p 25
###xml 477 481 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ubuka4">[30]</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ubuka6">[36]</xref>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Kirby1">[37]</xref>
###xml 620 624 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Emons1">[38]</xref>
###xml 625 629 625 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Millar2">[40]</xref>
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 126 131 <span type="species:ncbi:9606">human</span>
###xml 1052 1057 <span type="species:ncbi:9606">Human</span>
The identification of novel RFamide-related peptides (RFRP-1 and RFRP-3) in the human hypothalamus and the demonstration that human RFRP-3 has potent inhibitory actions on gonadotropin secretion in animal models opens up new vistas for understanding the regulation of reproduction. Many factors such as stress, anorexia, diabetes, obesity and photoperiod inhibit gonadotropin secretion. The possible role of GnIH in mediating these effects has been implicated in animal models [30], [36], [37]. GnRH analogues are extensively employed to manipulate the hypothalamic-pituitary-gonadal axis in various clinical conditions [38]-[40]. In view of its potent inhibition of gonadotropes, GnIH has the potential of an alternative or adjunct therapeutic agent to inhibit gonadotropins and steroid hormones. Thus this endogenous inhibitor of gonadotropin secretion has therapeutic potential in the treatment of hormone-dependent diseases such as precocious puberty, endometriosis, uterine fibroids, benign prostatic hyperplasia and prostatic and breast cancers. Human GnIH may also have potential as a novel contraceptive.
###end p 25
###begin title 26
Materials and Methods
###end title 26
###begin title 27
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human hypothalamus and pituitary tissue
###end title 27
###begin p 28
###xml 23 28 <span type="species:ncbi:9606">human</span>
Frozen and fixed adult human hypothalamus and pituitary tissue were obtained from Harvard Brain Tissue Resource Center (Belmont, MA). All donations were with fully informed consent by written statements from the deceased individuals. The research was approved by the ethics committee of the Harvard Brain Tissue Resource Center, McLean Hospital (Belmont, MA) (Director: Francine M. Benes, M.D., Ph.D.) and the IRB. All procedures were performed in accordance with the NIH Guide and under an approved protocol from the University of California.
###end p 28
###begin title 29
###xml 23 28 <span type="species:ncbi:9606">human</span>
Immunocytochemistry of human GnIH peptide
###end title 29
###begin p 30
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ubuka3">[19]</xref>
###xml 256 257 252 253 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 258 259 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 733 734 723 724 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1372 1374 1362 1364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1416 1417 1406 1407 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1445 1446 1435 1436 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1482 1483 1472 1473 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1514 1515 1504 1505 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1565 1567 1555 1557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 1726 1728 1716 1718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 161 166 <span type="species:ncbi:9606">human</span>
###xml 678 684 <span type="species:ncbi:9986">rabbit</span>
###xml 863 867 <span type="species:ncbi:9925">goat</span>
###xml 873 879 <span type="species:ncbi:9986">rabbit</span>
###xml 1236 1241 <span type="species:ncbi:9606">human</span>
###xml 1387 1392 <span type="species:ncbi:9606">human</span>
###xml 1420 1425 <span type="species:ncbi:9606">human</span>
###xml 1449 1454 <span type="species:ncbi:9606">human</span>
###xml 1580 1585 <span type="species:ncbi:9606">human</span>
###xml 1597 1602 <span type="species:ncbi:9606">human</span>
###xml 1745 1750 <span type="species:ncbi:9606">human</span>
Immunocytochemical analysis of GnIH was conducted with slight modifications of our previous method [19] on coronal sections at 40 microm thickness of five fixed human hypothalami. Sections were first post-fixed in 4% PFA for 30 min, and incubated in 0.3% H2O2 in absolute methanol for 20 min to suppress endogenous peroxidase activity after washing the sections three times in phosphate-buffered saline (PBS; 10 mM phosphate buffer, 0.14 M NaCl, pH 7.4). Sections were washed three times in PBS and incubated overnight at 4degreesC in the primary antibody at a concentration of 1:5,000 in PBS-T (0.2% Triton X-100 in PBS). The primary antibody used was affinity column purified rabbit anti-white-crowned sparrow GnIH (SIKPFSNLPLRF-NH2) antibody (code: PAC 123/124, G.E.B.). The next day, three subsequent washes in PBS were followed by incubation in biotinylated goat anti-rabbit IgG (1:250 in PBS-T) for 1 h. After washing the sections in PBS-T three times, they were incubated for 1 h in avidin-biotin complex (ABC; Vectastain Elite Kit, Vector Laboratories, Burlingame, CA) in PBS-T. The resulting complex was visualized using 0.03% 3,3 diaminobenzidine (DAB) after washing the sections three times in PBS-T. After the structures of human GnIH peptides were indentified, the specificity of the primary antibody was assessed by adsorption tests of the antibody with 1x10-6 M synthetic human RFRP-1 (MPHSFANLPLRF-NH2), human RFRP-3 (VPNLPQRF-NH2), human NPAF (AGEGLNSQFWSLAAPQRF-NH2) and kisspeptin (YNWNSFGLRF-NH2). Incubation of the avian GnIH antibody with 1x10-6 M synthetic human RFRP-1 and human RFRP-3 completely inhibited the staining. However, the staining was not inhibited by incubating the GnIH antibody with 1x10-6 M kisspeptin or human NPAF.
###end p 30
###begin title 31
Double-labeling immunocytochemistry of GnIH and GnRH
###end title 31
###begin p 32
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ubuka3">[19]</xref>
###xml 342 343 342 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 344 345 344 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1156 1157 1150 1151 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1230 1231 1224 1225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1264 1265 1258 1259 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1529 1533 1523 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Urbanski1">[41]</xref>
###xml 510 514 <span type="species:ncbi:9925">goat</span>
###xml 757 761 <span type="species:ncbi:9925">goat</span>
###xml 767 773 <span type="species:ncbi:9986">rabbit</span>
###xml 974 980 <span type="species:ncbi:9986">rabbit</span>
###xml 1632 1636 <span type="species:ncbi:9925">goat</span>
###xml 1642 1648 <span type="species:ncbi:9986">rabbit</span>
To determine the relative neuroanatomical distribution of GnIH and GnRH peptides, double-labeling immunocytochemistry of GnIH and GnRH neurons was performed with slight modifications of our previous method [19]. First, sections were fixed in 4% PFA for 30 min, and after washing the sections with PBS three times they were incubated in 0.3% H2O2 in absolute methanol for 20 min to inactivate endogenous peroxidase activity. After washing the sections in PBS three times and immersing the sections in 2% normal goat serum in PBS-T, sections were incubated overnight at 4degreesC in the white-crowned sparrow GnIH antibody in PBS-T at a concentration of 1:5000. The next day, three subsequent washes in PBS were followed by incubation for 1 h in biotinylated goat anti-rabbit IgG (1:250 in PBS-T). Sections were then incubated for 1 h in ABC, and the resulting complex was visualized using Vector VIP (Vector Laboratories). The primary antibody used to label GnRH neurons was rabbit anti-GnRH (HU60H; kindly donated by Dr. H. Urbanski) at a concentration of 1:5000 in PBS-T. The HU60 (bleed H) antiserum was generated against mammalian GnRH-I (pEHWSYGLRPG-NH2). HU60 equally recognizes mammalian GnRH-I, avian GnRH-I (pEHWSYGLQPG-NH2) and salmon GnRH (pEHWSYGWLPG-NH2). On the other hand, the antiserum shows no cross-reactivity with GnRH-free acid or GnRH fragments as well as other neuropeptides, including growth hormone-releasing hormone, oxytocin, somatostatin, thyrotropin-releasing hormone and vasoactive intestinal peptide [41]. The next day, three subsequent washes in PBS were followed by incubation for 1 h in biotinylated goat anti-rabbit IgG. Sections were then incubated for 1 h in ABC, and the resulting complex was visualized using DAB. Thus GnIH fibers were labeled in purple by Vector VIP, whereas GnRH neurons were labeled in brown by DAB.
###end p 32
###begin title 33
###xml 53 58 <span type="species:ncbi:9606">human</span>
Immunoaffinity purification and mass spectrometry of human GnIH peptide
###end title 33
###begin p 34
###xml 172 175 172 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Tsutsui1">[9]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ukena3">[42]</xref>
###xml 728 732 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ukena4">[43]</xref>
###xml 1618 1619 1606 1607 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1650 1651 1638 1639 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 189 194 <span type="species:ncbi:9606">human</span>
###xml 1621 1626 <span type="species:ncbi:9606">human</span>
###xml 1653 1658 <span type="species:ncbi:9606">human</span>
###xml 1749 1754 <span type="species:ncbi:9606">human</span>
To identify the structure of the mature human GnIH peptide, we first collected GnIH-ir material from brain extract as follows, using an antiserum raised against quail GnIH [9]. Five frozen human hypothalami (total weight 5.8 g) were boiled and homogenized in 5% acetic acid, as described previously [42]. The homogenate was centrifuged at 10,000 g for 30 min at 4degreesC, and the supernatant was collected. The collected supernatant was passed through a disposable C-18 cartridge column (Mega Bond-Elut; Varian, Harbor, CA, USA). The retained material eluted with 60% methanol was concentrated by using an evaporator and loaded onto an immunoaffinity column. The affinity chromatography was carried out as previously described [43]. The antiserum against quail GnIH was conjugated to cyanogen bromide-activated Sepharose 4B (Amersham Pharmacia Biotech, Uppsala, Sweden) as an affinity ligand. The concentrated material was applied to the immunoaffinity column at 4degreesC and the adsorbed materials were eluted with 0.3 M acetic acid containing 0.1% 2-mercaptoethanol. The eluted fractions were again concentrated and subjected to a reversed-phase HPLC column (ODS-80TM; Tosoh, Tokyo, Japan) with a linear gradient of 10-50% acetonitrile containing 0.1% trifluoroacetic acid at a flow rate of 0.5 ml/min, and fractionated every 2 min for 100 min. The immunoreactive fraction was assayed by a dot immunoblot assay and the molecular mass of the material was analyzed by matrix-assisted laser desorption/ionization-time-of-flight-mass spectrometry (MALDI-TOF MS; AXIMA-CFR-plus, Shimadzu, Kyoto, Japan). MPHSFANLPLRF-NH2 (human RFRP-1) and VPNLPQRF-NH2 (human RFRP-3) were predicted as the mature peptides from the deduced amino acid sequence of the human genome sequence. Accordingly, the peptide was synthesized by using a peptide synthesizer (PSSM-8; Shimadzu) and the molecular behavior of the synthetic and native peptides was compared by MALDI-TOF MS. Furthermore, fragmentation of the synthetic and native peptides were analyzed by tandem MS.
###end p 34
###begin title 35
###xml 29 34 <span type="species:ncbi:9606">human</span>
RT-PCR and DNA sequencing of human RFRP receptor cDNA
###end title 35
###begin p 36
###xml 525 555 525 555 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATGTTCATCCTCAACCTGGCTGTC-3&#8242;</named-content>
###xml 580 610 580 610 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTGTGGACAACCTCATCACTGGGT-3&#8242;</named-content>
###xml 635 665 635 665 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTTTCACACTGGTGGCCATTGCTG-3&#8242;</named-content>
###xml 697 728 697 728 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATGCGGGCGTACATGACCACGATGA-3&#8242;</named-content>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 31 36 <span type="species:ncbi:9606">human</span>
###xml 99 104 <span type="species:ncbi:9606">human</span>
###xml 377 382 <span type="species:ncbi:9606">human</span>
###xml 447 452 <span type="species:ncbi:9606">human</span>
One human hypothalamus and one human pituitary were used for the identification of a cDNA encoding human GPR147. Total RNA (including rRNA and mRNA) was isolated by using TRIZOL (Invitrogen, Carlsbad, CA). Total RNA was reverse transcribed using oligo(deoxythymidine)15 primer (Promega, Madison, WI) and reverse transcriptase (M-MLV Reverse Transcriptase; Invitrogen). Partial human GPR147 cDNA was amplified by PCR using various primers based on human GPR147 cDNA sequence (NM_022146). Combinations of forward primer 1 (F1: 5'-ATGTTCATCCTCAACCTGGCTGTC-3'), forward primer 2 (F2: 5'-TTGTGGACAACCTCATCACTGGGT-3'), forward primer 3 (F3: 5'-TTTTCACACTGGTGGCCATTGCTG-3') against a reverse primer (R1: 5'-ATGCGGGCGTACATGACCACGATGA-3') produced PCR products. All PCR amplifications were performed in a reaction mixture containing Taq polymerase (TaKaRa Ex TaqTM; Takara Bio Inc., Shiga, Japan). PCR products were sub-cloned into a pGEM-T Easy vector (Promega) and the DNA inserts of the positive clones were amplified by PCR with universal M13 primers. Amplified DNA was sequenced at the UC Berkeley DNA sequencing facility (Berkeley, CA) using 3730xl DNA Analyzer (Applied Biosystems, Foster City, CA).
###end p 36
###begin title 37
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 26 31 <span type="species:ncbi:9606">human</span>
In situ hybridization for human GnIH receptor, GPR147, mRNA and double staining with LH ICC
###end title 37
###begin p 38
###xml 143 150 133 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 230 234 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008400-Ubuka6">[36]</xref>
###xml 1842 1849 1816 1823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 1403 1408 <span type="species:ncbi:9940">sheep</span>
Coronal sections at 40 microm thickness of four frozen human pituitaries were collected on a cryostat at -20degreesC for histological studies. In situ hybridization was carried out with slight modifications of our previous method [36] using a digoxigenin (DIG)-labeled antisense RNA probe. The DIG-labeled antisense RNA probe was produced using a standard RNA labeling kit (Roche Diagnostics) by using partial GPR147 cDNA (nt 302-716 in NM_022146) as a template. Defrosted sections were first fixed in 4% paraformaldehyde (PFA) for 30 min. After washing the sections three times in PBS, they were incubated in 1 microg/ml proteinase K (Sigma-Aldrich, Saint Louis, MO) in PBS at 37degreesC for 30 min. Sections were fixed again in 4% PFA for 10 min, and then treated with 0.2 N HCl for 10 min after rinsing the sections in DEPC. The sections were again rinsed in DEPC twice and pre-incubated in 50% deionized formamide in 5X SSC (Roche Diagnostics) before the hybridization. Hybridization was carried out overnight at 50degreesC in 50% deionized formamide, 50% hybridization solution (2X concentrate, buffered with SSC, Sigma-Aldrich) at the probe concentrations of 200 ng/ml. After the hybridization, the sections were washed twice in 2X SCC in 50% formamide, and twice in 1X SSC in 50% formamide for 15 min each. After rinsing the sections in PBS, they were incubated with alkaline phosphatase-labeled sheep anti-DIG antibody (Roche Diagnostics) in 1.5% DIG blocking reagent (Roche Diagnostics) in PBS. After rinsing the sections three times in PBS and once in alkaline phosphate buffer (pH 9.5), the immunoreactive product was visualized by immersing the sections in a substrate solution (nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl phosphate stock solution; Roche Diagnostics) in alkaline phosphate buffer. Control for specificity of in situ hybridization was performed by using a DIG-labeled sense RNA probe, the sequence of which was complementary to the antisense probe.
###end p 38
###begin p 39
###xml 102 108 102 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n situ</italic>
###xml 127 132 <span type="species:ncbi:9606">human</span>
###xml 161 166 <span type="species:ncbi:9606">human</span>
###xml 266 272 <span type="species:ncbi:9986">rabbit</span>
###xml 289 294 <span type="species:ncbi:9606">human</span>
###xml 419 423 <span type="species:ncbi:9925">goat</span>
###xml 429 435 <span type="species:ncbi:9986">rabbit</span>
Immunocytochemical analyses of LH were further conducted on the same sections previously labelled by in situ hybridization for human GPR147 mRNA. After labeling human GPR147 mRNA, the sections were washes in PBS three times and incubated overnight at 4degreesC in a rabbit polyclonal anti-human LH antiserum, (Affinity bioreagents, Golden, CO). The next day, after three washes in PBS, the sections were incubated with goat anti-rabbit IgG conjugated to Alexa Fluor 568 (Molecular Probes Inc., Eugene, OR).
###end p 39
###begin title 40
Image processing
###end title 40
###begin p 41
Microscopic images were acquired digitally on an Axio Imager, A1 microscope (Carl Zeiss AG, Gottingen, Germany) with an AxioCam MRc5 digital camera (Carl Zeiss AG) using AxioVision Rel. 4.5 software package (Carl Zeiss AG). Fluorescent images were excited by using HBO 100 microscope illuminating system (Carl Zeiss AG). The brightness, contrast, sharpness and the size of the images were adjusted using Adobe Photoshop CS2 (Adobe Systems, San Jose, CA).
###end p 41
###begin p 42
###xml 66 71 <span type="species:ncbi:9606">human</span>
###xml 86 91 <span type="species:ncbi:9606">Human</span>
We thank Professor Marian Diamond (UC Berkeley) for her help with human neuroanatomy. Human brain tissue was provided by the Harvard Brain Tissue resource Center. Some brain tissue was also provided by John Collin, M.D.
###end p 42
###begin title 43
References
###end title 43
###begin article-title 44
Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence.
###end article-title 44
###begin article-title 45
Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation).
###end article-title 45
###begin article-title 46
###xml 13 20 <span type="species:ncbi:9031">chicken</span>
Structure of chicken hypothalamic luteinizing hormone-releasing hormone. I. Structural determination on partially purified material.
###end article-title 46
###begin article-title 47
###xml 13 20 <span type="species:ncbi:9031">chicken</span>
Structure of chicken hypothalamic luteinizing hormone-releasing hormone. II. Isolation and characterization.
###end article-title 47
###begin article-title 48
###xml 39 46 <span type="species:ncbi:9031">chicken</span>
1982 Isolation and characterization of chicken hypothalamic luteinizing hormone-releasing hormone.
###end article-title 48
###begin article-title 49
Hypothalamic pituitary stimulating and inhibiting hormones.
###end article-title 49
###begin article-title 50
Partial purification of a hypothalamic factor that inhibits gonadotropin-releasing hormone-stimulated luteinizing hormone release.
###end article-title 50
###begin article-title 51
###xml 97 102 <span type="species:ncbi:9606">human</span>
In vitro bioactivity of gonadotrophin surge attenuating factor is not affected by an antibody to human inhibin.
###end article-title 51
###begin article-title 52
A novel avian hypothalamic peptide inhibiting gonadotropin release.
###end article-title 52
###begin article-title 53
Distribution of a novel avian gonadotropin-inhibitory hormone in the quail brain.
###end article-title 53
###begin article-title 54
###xml 80 97 80 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Coturnix japonica</italic>
###xml 64 78 <span type="species:ncbi:93934">Japanese quail</span>
###xml 80 97 <span type="species:ncbi:93934">Coturnix japonica</span>
Developmental changes in gonadotropin-inhibitory hormone in the Japanese quail (Coturnix japonica) hypothalamo-hypophysial system.
###end article-title 54
###begin article-title 55
Characterization of a cDNA encoding a novel avian hypothalamic neuropeptide exerting an inhibitory effect on gonadotropin release.
###end article-title 55
###begin article-title 56
###xml 67 98 67 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Zonotrichia leucophrys gambelii</italic>
###xml 67 98 <span type="species:ncbi:257770">Zonotrichia leucophrys gambelii</span>
Gonadotropin-inhibitory hormone in Gambel's white-crowned sparrow (Zonotrichia leucophrys gambelii): cDNA identification, transcript localization and functional effects in laboratory and field experiments.
###end article-title 56
###begin article-title 57
###xml 94 111 94 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Coturnix japonica</italic>
###xml 78 92 <span type="species:ncbi:93934">Japanese quail</span>
###xml 94 111 <span type="species:ncbi:93934">Coturnix japonica</span>
A novel G protein-coupled receptor for gonadotropin-inhibitory hormone in the Japanese quail (Coturnix japonica): identification, expression and binding activity.
###end article-title 57
###begin article-title 58
###xml 153 160 <span type="species:ncbi:9031">chicken</span>
Gonadotrophin inhibitory hormone depresses gonadotrophin alpha and follicle-stimulating hormone beta subunit expression in the pituitary of the domestic chicken.
###end article-title 58
###begin article-title 59
Gonadotropin-inhibitory hormone inhibits gonadal development and maintenance by decreasing gonadotropin synthesis and release in male quail.
###end article-title 59
###begin article-title 60
###xml 50 67 50 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Melospiza melodia</italic>
###xml 130 147 130 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Passer domesticus</italic>
###xml 35 48 <span type="species:ncbi:44397">song sparrows</span>
###xml 50 67 <span type="species:ncbi:44397">Melospiza melodia</span>
###xml 114 128 <span type="species:ncbi:48849">house sparrows</span>
###xml 130 147 <span type="species:ncbi:48849">Passer domesticus</span>
###xml 161 168 <span type="species:ncbi:9031">chicken</span>
Gonadotropin-inhibitory peptide in song sparrows (Melospiza melodia) in different reproductive conditions, and in house sparrows (Passer domesticus) relative to chicken-gonadotropin-releasing hormone.
###end article-title 60
###begin article-title 61
Rapid inhibition of female sexual behavior by gonadotropin-inhibitory hormone (GnIH).
###end article-title 61
###begin article-title 62
###xml 124 132 <span type="species:ncbi:9172">starling</span>
Gonadotropin-inhibitory hormone neurons interact directly with gonadotropin-releasing hormone-I and -II neurons in European starling brain. Endocrinology 149:268-278.
###end article-title 62
###begin article-title 63
A new member of the hypothalamic RF-amide peptide family, LPXRF-amide peptides: structure, localization, and function.
###end article-title 63
###begin article-title 64
Hypothalamic LPXRF-amide peptides in vertebrates: identification, localization and hypophysiotropic activity.
###end article-title 64
###begin article-title 65
Recent advances in mammalian RFamide peptides: the discovery and functional analyses of PrRP, RFRPs and QRFP.
###end article-title 65
###begin article-title 66
Identification and characterization of a gonadotropin-inhibitory system in the brains of mammals.
###end article-title 66
###begin article-title 67
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
###xml 137 140 <span type="species:ncbi:10116">rat</span>
Rat RFamide-related peptide-3 stimulates GH secretion, inhibits LH secretion, and has variable effects on sex behavior in the adult male rat.
###end article-title 67
###begin article-title 68
###xml 104 108 <span type="species:ncbi:10116">rats</span>
Hypophysiotropic role of RFamide-related peptide-3 (RFRP-3) in the inhibition of LH secretion in female rats.
###end article-title 68
###begin article-title 69
Potent action of RFRP-3 on pituitary gonadotropes indicative of an hypophysiotropic role in the negative regulation of gonadotropin secretion.
###end article-title 69
###begin article-title 70
Effect of RF-amide-related peptide-3 on luteinizing hormone and follicle-stimulating hormone synthesis and secretion in ovine pituitary gonadotropes.
###end article-title 70
###begin article-title 71
###xml 0 6 <span type="species:ncbi:9913">Bovine</span>
###xml 161 168 <span type="species:ncbi:9913">bovines</span>
Bovine C-terminal octapeptide of RFamide-related peptide-3 suppresses luteinizing hormone (LH) secretion from the pituitary as well as pulsatile LH secretion in bovines.
###end article-title 71
###begin article-title 72
New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals.
###end article-title 72
###begin article-title 73
The control of reproductive physiology and behavior by gonadotropin-inhibitory hormone.
###end article-title 73
###begin article-title 74
###xml 170 175 <span type="species:ncbi:9940">sheep</span>
Variation in kisspeptin and gonadotropin-inhibitory hormone expression and terminal connections to GnRH neurons in the brain: a novel medium for seasonal breeding in the sheep.
###end article-title 74
###begin article-title 75
###xml 82 96 <span type="species:ncbi:9544">rhesus macaque</span>
Gonadotropin-inhibitory hormone identification, cDNA cloning, and distribution in rhesus macaque brain.
###end article-title 75
###begin article-title 76
Gonadotropin inhibitory hormone inhibits basal forebrain vGluT2-gonadotropin-releasing hormone neurons via a direct postsynaptic mechanism.
###end article-title 76
###begin article-title 77
###xml 159 164 <span type="species:ncbi:10090">mouse</span>
RFamide-related peptide-3 (RFRP-3), a mammalian gonadotropin-inhibitory hormone ortholog, regulates gonadotropin-releasing hormone (GnRH) neuron firing in the mouse.
###end article-title 77
###begin article-title 78
###xml 110 114 <span type="species:ncbi:10116">rats</span>
Central and peripheral effects of RFamide-related peptide-3 on luteinizing hormone and prolactin secretion in rats.
###end article-title 78
###begin article-title 79
Melatonin induces the expression of gonadotropin-inhibitory hormone in the avian brain.
###end article-title 79
###begin article-title 80
###xml 100 104 <span type="species:ncbi:10116">rats</span>
Stress increases putative gonadotropin inhibitory hormone and decreases luteinizing hormone in male rats.
###end article-title 80
###begin article-title 81
The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers.
###end article-title 81
###begin article-title 82
Progress towards the development of non-peptide orally-active gonadotropin-releasing hormone (GnRH) antagonists: therapeutic implications.
###end article-title 82
###begin article-title 83
Gonadotropin-releasing hormone receptors.
###end article-title 83
###begin article-title 84
Influence of photoperiod and 6-methoxybenzoxazolinone on the reproductive axis of inbred LSH/Ss Lak male hamsters.
###end article-title 84
###begin article-title 85
Novel neuropeptides related to frog growth hormone-releasing peptide: isolation, sequence, and functional analysis.
###end article-title 85
###begin article-title 86
###xml 8 11 <span type="species:ncbi:10116">rat</span>
A novel rat hypothalamic RFamide-related peptide identified by immunoaffinity chromatography and mass spectrometry.
###end article-title 86
###begin p 87
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 87
###begin p 88
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Hellmann Family Foundation Fund (to G.E.B.), UC Berkeley COR Junior Faculty Research Grant (to G.E.B.), National Science Foundation (to G.E.B.), Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan (to K.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 88

